Problems Related to Resistance to Cytarabine in Acute Myeloid Leukemia
- 1 June 2004
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 45 (6), 1123-1132
- https://doi.org/10.1080/1042819032000159861
Abstract
(2004). Problems Related to Resistance to Cytarabine in Acute Myeloid Leukemia. Leukemia & Lymphoma: Vol. 45, No. 6, pp. 1123-1132.Keywords
This publication has 37 references indexed in Scilit:
- In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemiaBritish Journal of Haematology, 2002
- P‐glycoprotein, lung resistance‐related protein and multidrug resistance associated protein in de novo acute non‐lymphocytic leukaemias: biological and clinical implicationsBritish Journal of Haematology, 1999
- 3′-Phosphorylated Nucleotides Are Tight Binding Inhibitors of Nucleoside Diphosphate Kinase ActivityJournal of Biological Chemistry, 1998
- Es Nucleoside Transporter Content of Acute Leukemia Cells: Role in Cell Sensitivity to Cytarabine (araC)Leukemia & Lymphoma, 1998
- Pharmacokinetics of High-Dose Cytarabine and its Deamination Product-A ReappraisalLeukemia & Lymphoma, 1997
- Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemiaBlood, 1996
- Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells.JCI Insight, 1987
- Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.JCI Insight, 1985
- Cytosine Arabinoside Influx and Nucleoside Transport Sites in Acute LeukemiaJCI Insight, 1982
- Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.Proceedings of the National Academy of Sciences, 1981